406 related articles for article (PubMed ID: 28478500)
1. Comparison of long-term voice outcomes after vocal fold augmentation using autologous fat injection by direct microlaryngoscopy versus office-based calcium hydroxylapatite injection.
Zeleník K; Walderová R; Kučová H; Jančatová D; Komínek P
Eur Arch Otorhinolaryngol; 2017 Aug; 274(8):3147-3151. PubMed ID: 28478500
[TBL] [Abstract][Full Text] [Related]
2. Five-year results of vocal fold augmentation using autologous fat or calcium hydroxylapatite.
Zeleník K; Formánek M; Walderová R; Formánková D; Komínek P
Eur Arch Otorhinolaryngol; 2021 Apr; 278(4):1139-1144. PubMed ID: 33226462
[TBL] [Abstract][Full Text] [Related]
3. Comparison of voice outcome after vocal fold augmentation with fat or calcium hydroxylapatite.
Lodder WL; Dikkers FG
Laryngoscope; 2015 May; 125(5):1161-5. PubMed ID: 25545723
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Patients with Vocal Fold Atrophy and Comorbid Essential Voice Tremor: Long-Term Injection Augmentation Outcomes After Successful Diagnostic Vocal Fold Injection Augmentation.
Van Doren M; Faudoa E; Carroll TL
J Voice; 2020 May; 34(3):471-476. PubMed ID: 30503608
[TBL] [Abstract][Full Text] [Related]
5. Vocal fold augmentation with injectable calcium hydroxylapatite: short-term results.
Rosen CA; Thekdi AA
J Voice; 2004 Sep; 18(3):387-91. PubMed ID: 15331112
[TBL] [Abstract][Full Text] [Related]
6. Vocal fold augmentation with calcium hydroxylapatite: twelve-month report.
Rosen CA; Gartner-Schmidt J; Casiano R; Anderson TD; Johnson F; Remacle M; Sataloff RT; Abitbol J; Shaw G; Archer S; Zraick RI
Laryngoscope; 2009 May; 119(5):1033-41. PubMed ID: 19274731
[TBL] [Abstract][Full Text] [Related]
7. Multidimensional assessment of voice quality after injection augmentation of the vocal fold with autologous adipose tissue or calcium hydroxylapatite.
Mes SD; Smajlović E; Heijnen BJ; Hendriksma M; Jansen JC; Langeveld APM; Sjögren EV
Eur Arch Otorhinolaryngol; 2022 Apr; 279(4):1967-1978. PubMed ID: 34846572
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 24-month voice outcomes after injection laryngoplasty with calcium hydroxylapatite or hyaluronic acid in patients with unilateral vocal fold paralysis.
Miaśkiewicz B; Panasiewicz A; Nikiel K; Włodarczyk E; Gos E; Szkiełkowska A
Am J Otolaryngol; 2022; 43(1):103207. PubMed ID: 34537510
[TBL] [Abstract][Full Text] [Related]
9. [Vocal fold augmentation by injection of autologous fascia and fat].
Zhang HY; Xu W; Lü ZH; Zou JD; Cao HY; Wang HB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Apr; 46(4):269-74. PubMed ID: 21624243
[TBL] [Abstract][Full Text] [Related]
10. Vocal fold augmentation with calcium hydroxylapatite (CaHA).
Rosen CA; Gartner-Schmidt J; Casiano R; Anderson TD; Johnson F; Reussner L; Remacle M; Sataloff RT; Abitbol J; Shaw G; Archer S; McWhorter A
Otolaryngol Head Neck Surg; 2007 Feb; 136(2):198-204. PubMed ID: 17275539
[TBL] [Abstract][Full Text] [Related]
11. Office-based Autologous Fat Injection Laryngoplasty for Vocal Process Granuloma.
Hu HC; Hung YT; Lin SY; Chang SY
J Voice; 2016 Nov; 30(6):758.e7-758.e11. PubMed ID: 26454769
[TBL] [Abstract][Full Text] [Related]
12. Vocal fold augmentation with calcium hydroxylapatite.
Belafsky PC; Postma GN
Otolaryngol Head Neck Surg; 2004 Oct; 131(4):351-4. PubMed ID: 15467598
[TBL] [Abstract][Full Text] [Related]
13. Vocal cord medialization by transcutaneous injection of calcium hydroxylapatite.
Hughes RG; Morrison M
J Voice; 2005 Dec; 19(4):674-8. PubMed ID: 16301109
[TBL] [Abstract][Full Text] [Related]
14. Injection laryngoplasty outcomes in irradiated and nonirradiated unilateral vocal fold paralysis.
Chang J; Courey MS; Al-Jurf SA; Schneider SL; Yung KC
Laryngoscope; 2014 Aug; 124(8):1895-9. PubMed ID: 24473831
[TBL] [Abstract][Full Text] [Related]
15. Perception and duration of pain after office-based vocal fold injection augmentation.
Crawley BK; Dehom S; Kutzner E; Murry T; Krishna P; Hata J
Laryngoscope; 2018 Apr; 128(4):929-934. PubMed ID: 29355978
[TBL] [Abstract][Full Text] [Related]
16. The use of injectable calcium hydroxylapatite in the surgically pretreated larynx with glottal insufficiency.
Caffier PP; I Nasr A; Weikert S; Rummich J; Gross M; Nawka T
Laryngoscope; 2017 May; 127(5):1125-1130. PubMed ID: 27578371
[TBL] [Abstract][Full Text] [Related]
17. Laryngoplasty with hyaluronic acid in patients with unilateral vocal fold paralysis.
Reiter R; Brosch S
J Voice; 2012 Nov; 26(6):785-91. PubMed ID: 22578435
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of trans-nasal fiberendoscopic injection laryngoplasty with centrifuged autologous fat in the treatment of glottic insufficiency due to unilateral vocal fold paralysis.
Ricci Maccarini A; Stacchini M; Mozzanica F; Schindler A; Basile E; DE Rossi G; Woo P; Remacle M; Magnani M
Acta Otorhinolaryngol Ital; 2018 Jun; 38(3):204-213. PubMed ID: 29984796
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of voice outcome comparing calcium hydroxylapatite injection laryngoplasty to silicone thyroplasty.
Shen T; Damrose EJ; Morzaria S
Otolaryngol Head Neck Surg; 2013 Feb; 148(2):197-208. PubMed ID: 23077153
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis on the efficiency of the injection laryngoplasty technique using calcium hydroxyapatite (CaHA): the thyrohyoid approach versus the cricothyroid approach.
Woo SH; Son YI; Lee SH; Park JJ; Kim JP
J Voice; 2013 Mar; 27(2):236-41. PubMed ID: 23280385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
